AF
QNCX icon

Allworth Financial’s Quince Therapeutics QNCX Stock Holding History

Allworth Financial’s Portfolio QNCX Stock Details QNCX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$137 Buy
+8
New +$184 ﹤0.01% 5000
2026
Q1 		– Sell
-8
Closed -$5.03K – 5294
2025
Q4 		$5.03K Buy
+8
New +$4.03K ﹤0.01% 3709
2023
Q4 		– Sell
-1
Closed -$300 – 3586
2023
Q3 		$300 Hold
1
– – ﹤0.01% 3169
2023
Q2 		$402 Hold
1
– – ﹤0.01% 2936
2023
Q1 		$417 Buy
+1
New +$196 ﹤0.01% 2877

Other funds holding QNCX

Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
SCM
Squadron Capital Management Westmont, Illinois $322M AUM
SC
Shay Capital New York $1.56B AUM 46.17% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Allworth Financial's QNCX Position: Q2 2026 in Review

Allworth Financial opened a new position in Quince Therapeutics (QNCX) in Q2 2026: 8 shares worth $137. The stake represents ﹤0.01% of the portfolio and ranks #5000 among its holdings. This is a return to the name: Allworth Financial previously reported a position in QNCX as recently as Q4 2025.

Allworth Financial first reported a position in QNCX in Q1 2023 and has held it in 5 quarters since. The position peaked at $5.03K in Q4 2025. 27 funds tracked by Wall St. Rank hold QNCX as of Q2 2026.

  • Allworth Financial held 8 shares of Quince Therapeutics worth $137 as of Q2 2026.
  • Quince Therapeutics was a new Allworth Financial position in Q2 2026.
  • Quince Therapeutics made up ﹤0.01% of Allworth Financial's portfolio in Q2 2026, its #5000 holding.
  • Allworth Financial first reported a position in Quince Therapeutics in Q1 2023 and has held it in 5 quarters since.
  • Allworth Financial's Quince Therapeutics position peaked at $5.03K in Q4 2025.
  • 27 funds tracked by Wall St. Rank held Quince Therapeutics as of Q2 2026.

Based on Allworth Financial's 13F filing for Q2 2026, filed 11 Aug 2026.